Article
03 Oct 2025
Federal Circuit Clarifies Limits On Patentability Of Clinical Study Results-Based Applications
RANKINGS
This author falls within the Top 20% for their listed topics and industry categories. Based on Mondaq users readership, this author is ranked as VERY POPULAR in United States
AUTHORS CONTENT
Article
26 Sep 2025
Federal Circuit Clarifies Independent Conception Standard For AIA Derivation
Article
05 Sep 2025
Acting Director Reverses Previous Discretionary Denial
Article
28 Aug 2025
Bill Seeks To Restrict 30-Month Stay In Hatch-Waxman Litigation To One Patent
Article
03 Jul 2025
U.S. Supreme Court Invites Solicitor General To Submit Briefing On "Skinny Labels"
Article
27 Jun 2025
USPTO Acting Director Denies IPR Institution Based On "Settled Expectations"
Article
07 Apr 2025
PTAB Announces A Bifurcated Process For Consideration Of IPR And PGR Petitions
Article
19 Feb 2025
USPTO/PTAB: Changes Are On The Horizon
Article
03 Sep 2024
Federal Circuit Clarifies Scope Of Patent Owner Estoppel
Article
02 Aug 2024
Director Provides Reminders For Obviousness Analysis
Article
31 Jul 2024
U.S. Senate Unanimously Passes Bill Limiting Number Of Patents Asserted Against Biosimilar Applicants
Article
09 Jul 2024
Federal Circuit Revives Induced Infringement Claims Despite "Skinny Label" Carve-Out
Article
07 May 2024
Forced Cooperation Between Rivals Does Not Create A "Significant Relationship"
Article
01 Feb 2024
Federal Circuit Denies Petition For Rehearing En Banc Filed By Cellect, LLC
Article
08 Jan 2024
Penumbra Illuminates Priority Dates Pre And Post-AIA
Article
29 Dec 2023
Federal Agencies Seeking Patent Seizure Authority Through Draft NIST Guidance
Article
27 Apr 2023
Prior Conception Defeats Otherwise Sufficient Derivation Showing
Article
10 Feb 2023
Senate Judiciary Committee Revisits Drug Pricing Reform Bills
Article
26 Jan 2023
Disclaimer Made In IPR Not Binding In Same Proceeding
Article
25 Jan 2023
Food, Drugs, Cosmetics, And Devices: Federal Regulatory Focus Areas In 2023